Gritstone Announces Private Placement Financing of $55.0 Million

NEXT STORY
Novartis reports positive health-related quality of life data for 177Lu-PSMA-617 radioligand therapy in patients with advanced prostate cancer at ESMO 2021
PREV STORY
Inventiva announces major recruitments to accelerate the development of lanifibranor in NASH
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results

author_avatar
NASDAQ Market News

Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma

author_avatar
NASDAQ Market News